EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis

Alessio Maranzano, Federico Verde, Antonella Dubini, Silvia Torre, Eleonora Colombo, Alberto Doretti, Francesco Gentile, Arianna Manini, Ilaria Milone, Alberto Brusati, Silvia Peverelli, Serena Santangelo und 11 weitere

European Journal of Neurology · 2024-09 · 31 (9)

DOI: 10.1111/ene.16374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 10.06.2024. Verfasst von Alessio Maranzano und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Amyotrophic Lateral Sclerosis, Apolipoproteins E, Biomarkers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Little is known about amyotrophic lateral sclerosis (ALS)‐nonspecific cognitive deficits – most notably memory disturbance – and their biological underpinnings. We investigated the associations of the Alzheimer's disease (AD) genetic risk factor APOE and cerebrospinal fluid (CSF) biomarkers Aβ and tau proteins with cognitive and motor phenotype in ALS.

Methods

APOE haplotype was determined in 281 ALS patients; for 105 of these, CSF levels of Aβ42, Aβ40, total tau (T‐tau), and phosphorylated tau (P‐tau181) were quantified by chemiluminescence enzyme immunoassay (CLEIA). The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) was employed to evaluate the neuropsychological phenotype.

Results

APOE ‐E4 allele was associated with worse ECAS memory score (median, 14.0 in carriers vs. 16.0 in non‐carriers) and lower CSF Aβ42 (−0.8 vs. 0.1, log‐transformed values) and Aβ42/40 ratio (−0.1 vs. 0.3). Some 37.1% of ALS patients showed low Aβ42 levels, possibly reflecting cerebral Aβ deposition. While lower Aβ42/40 correlated with lower memory score ( β = 0.20), Aβ42 positively correlated with both ALS‐specific ( β = 0.24) and ALS‐nonspecific ( β = 0.24) scores. Although Aβ42/40 negatively correlated with T‐tau ( β = −0.29) and P‐tau181 ( β = −0.33), we found an unexpected positive association of Aβ42 and Aβ40 with both tau proteins. Regarding motor phenotype, lower levels of Aβ species were associated with lower motor neuron (LMN) signs (Aβ40: β = 0.34; Aβ42: β = 0.22).

Conclusions

APOE haplotype and CSF Aβ biomarkers are associated with cognitive deficits in ALS and particularly with memory impairment. This might partly reflect AD‐like pathophysiological processes, but additional ALS‐specific mechanisms could be involved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesAmyotrophic Lateral SclerosisApolipoproteins EBiomarkersPhenotypetau ProteinsAdultAgedFemaleHumansMaleMiddle AgedCognition DisordersGenotypePeptide Fragments

Stichwörter der Autor:innen

APOE genotypeAlzheimer's diseaseamyloid betaamyotrophic lateral sclerosistau proteins

Substanzen

Amyloid beta-Peptidesamyloid beta-protein (1-42)Apolipoproteins EBiomarkersMAPT protein, humanPeptide Fragmentstau ProteinsApoE protein, human

Autor:innen und Institutionen

  • Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Università degli Studi di Milano, Milan, Italy.
  • Department of Laboratory Medicine, Laboratory of Clinical Chemistry and Microbiology, IRCCS Istituto Auxologico Italiano, Milan, Italy.
  • Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Department of Brain and Behavioural Sciences, Università degli Studi di Pavia, Pavia, Italy.
  • Department of Medical Biotechnology and Molecular Medicine, Università degli Studi di Milano, Milan, Italy.

ORCID-Profile: Barbara Poletti, Antonia Ratti, Nicola Ticozzi

Förderung

  • Ministry of Health

Zitieren

APA

Maranzano, A., Verde, F., Dubini, A., Torre, S., Colombo, E., Doretti, A., Gentile, F., Manini, A., Milone, I., Brusati, A., Peverelli, S., Santangelo, S., Spinelli, E. G., Torresani, E., Gentilini, D., Messina, S., Morelli, C., Poletti, B., Agosta, F., …, & Ticozzi, N. (2024). Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis. European Journal of Neurology, 31(9). https://doi.org/10.1111/ene.16374

Vancouver

Maranzano A, Verde F, Dubini A, Torre S, Colombo E, Doretti A, et al. Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis. European Journal of Neurology. 2024;31(9). doi:10.1111/ene.16374

BibTeX
@article{Maranzano2024,
  author = {Maranzano, Alessio and Verde, Federico and Dubini, Antonella and Torre, Silvia and Colombo, Eleonora and Doretti, Alberto and Gentile, Francesco and Manini, Arianna and Milone, Ilaria and Brusati, Alberto and Peverelli, Silvia and Santangelo, Serena and Spinelli, Edoardo Gioele and Torresani, Erminio and Gentilini, Davide and Messina, Stefano and Morelli, Claudia and Poletti, Barbara and Agosta, Federica and Ratti, Antonia and Filippi, Massimo and Silani, Vincenzo and Ticozzi, Nicola},
  title = {Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis},
  journal = {European Journal of Neurology},
  year = {2024},
  volume = {31},
  number = {9},
  doi = {10.1111/ene.16374}
}
Kostenlos starten →